Search Results

There are 63968 results for: content related to: Prognostic factors in multiple myeloma in a population-based trial

  1. You have free access to this content
    Skeletal survey in advanced multiple myeloma: radiographic versus MR imaging survey

    British Journal of Haematology

    Volume 106, Issue 1, July 1999, Pages: 35–39, Frédéric E. Lecouvet, Jacques Malghem, Lucienne Michaux, Baudouin Maldague, Augustin Ferrant, Jean-Louis Michaux and Bruno C. Vande Berg

    Article first published online : 25 DEC 2001, DOI: 10.1046/j.1365-2141.1999.01529.x

  2. Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma

    European Journal of Haematology

    Volume 80, Issue 6, June 2008, Pages: 490–494, Martin Kaiser, Maren Mieth, Peter Liebisch, Romy Oberländer, Jessica Rademacher, Christian Jakob, Lorenz Kleeberg, Claudia Fleissner, Edgar Braendle, Malte Peters, David Stover, Orhan Sezer and Ulrike Heider

    Article first published online : 10 MAR 2008, DOI: 10.1111/j.1600-0609.2008.01065.x

  3. Osteoblast stimulation in multiple myeloma lacking lytic bone lesions

    British Journal of Haematology

    Volume 76, Issue 4, December 1990, Pages: 484–487, Régis Bataille, Daniel Chappard, Christian Marcelli, Jean-Franclois Rossi, Philippe Dessauw, Pierre Baldet, Jacques Sany And and Christian Alexandre

    Article first published online : 12 MAR 2008, DOI: 10.1111/j.1365-2141.1990.tb07904.x

  4. Improvement of Durie & Salmon staging for multiple myeloma by adding platelet count as a stratifying variable: A multivariate regression analysis of 163 untreated patients

    European Journal of Haematology

    Volume 43, Issue S51, December 1989, Pages: 99–104, Michele Cavo, Piero Galieni, Maria Grimaldi, Eliana Zuffa, Maria Angela Bonelli, Marco Gobbi and Sante Tura

    Article first published online : 24 APR 2009, DOI: 10.1111/j.1600-0609.1989.tb01500.x

  5. Polymorphisms in the heparanase gene in multiple myeloma association with bone morbidity and survival

    European Journal of Haematology

    Volume 94, Issue 1, January 2015, Pages: 60–66, Niels F. Andersen, Ulla Vogel, Tobias W. Klausen, Peter Gimsing, Henrik Gregersen, Niels Abildgaard and Annette J. Vangsted

    Article first published online : 16 JUL 2014, DOI: 10.1111/ejh.12401

  6. You have free access to this content
    Extent of disease burden determined with magnetic resonance imaging of the bone marrow is predictive of survival outcome in patients with multiple myeloma

    Cancer

    Volume 116, Issue 1, 1 January 2010, Pages: 84–92, Sikander Ailawadhi, Ahmed N. Abdelhalim, Lyudmyla Derby, Terry L. Mashtare, Kena C. Miller, Gregory E. Wilding, Ronald A. Alberico, Ronald Gottlieb, Donald L. Klippenstein, Kelvin Lee and Asher A. Chanan-Khan

    Article first published online : 27 OCT 2009, DOI: 10.1002/cncr.24704

  7. LYTIC BONE LESIONS IN AN AUSTRALIAN POPULATION: THE RESULTS OF 100 CONSECUTIVE BIOPSIES

    ANZ Journal of Surgery

    Volume 76, Issue 8, August 2006, Pages: 732–735, Mark T. Clayer

    Article first published online : 3 AUG 2006, DOI: 10.1111/j.1445-2197.2006.03843.x

  8. Non-invasive markers of bone turnover and plasma cytokines differ in osteoporotic patients with multiple myeloma and monoclonal gammopathies of undetermined significance

    Internal Medicine Journal

    Volume 31, Issue 5, July 2001, Pages: 272–278, T. Diamond, 1 S. Levy, 1 A. Smith, 2 P. Day and 2 A. Manoharan 3

    Article first published online : 21 DEC 2001, DOI: 10.1046/j.1445-5994.2001.00055.x

  9. Multiple myeloma: Intensified maintenance therapy with recombinant interferon-α-2b plus glucocorticoids

    European Journal of Haematology

    Volume 49, Issue 2, August 1992, Pages: 93–97, Antonio Palumbo, Mario Boccadoro, Lucia A. Garino, Gabriele Gallone, Roberto Frieri and Alessandro Pileri

    Article first published online : 24 APR 2009, DOI: 10.1111/j.1600-0609.1992.tb00037.x

  10. Myeloma

    Postgraduate Haematology, Fifth Edition

    Evangelos Terpos, Amin Rahemtulla, Pages: 681–702, 2007

    Published Online : 26 OCT 2007, DOI: 10.1002/9780470987056.ch41

  11. Multiple Myeloma in the Elderly

    Journal of the American Geriatrics Society

    Volume 42, Issue 6, June 1994, Pages: 653–664, Marc Gautier and Harvey Jay Cohen

    Article first published online : 27 APR 2015, DOI: 10.1111/j.1532-5415.1994.tb06866.x

  12. Treatment of Lytic Bone Metastases

    Textbook of Bone Metastases

    Robert E. Coleman, Karin Gwyn, Richard Theriault, Pages: 361–368, 2006

    Published Online : 3 JAN 2006, DOI: 10.1002/0470011610.ch28

  13. Response level and survival after conventional chemotherapy for multiple myeloma: a Finnish Leukaemia Group study

    European Journal of Haematology

    Volume 62, Issue 2, February 1999, Pages: 109–116, Tiina M. Oivanen, Pirkko Kellokumpu-Lehtinen, Anna-Maija Koivisto, Elli Koivunen, Ilmari Palva and Finnish Leukaemia Group

    Article first published online : 24 APR 2009, DOI: 10.1111/j.1600-0609.1999.tb01730.x

  14. Assessment of bone involvement in patients with multiple myeloma using bone densitometry

    European Journal of Haematology

    Volume 57, Issue 5, November 1996, Pages: 370–376, N. Abildgaard, K. Brixen, J. E. Kristensen, T. Vejlgaard, P. Charles and J. L. Nielsen

    Article first published online : 24 APR 2009, DOI: 10.1111/j.1600-0609.1996.tb01395.x

  15. You have free access to this content
    Review of phenotypic markers used in flow cytometric analysis of MGUS and MM, and applicability of flow cytometry in other plasma cell disorders

    British Journal of Haematology

    Volume 149, Issue 3, May 2010, Pages: 334–351, Karthick R. M. Raja, Lucie Kovarova and Roman Hajek

    Article first published online : 1 MAR 2010, DOI: 10.1111/j.1365-2141.2010.08121.x

  16. You have free access to this content
    Enhanced production of osteopontin in multiple myeloma: clinical and pathogenic implications

    British Journal of Haematology

    Volume 123, Issue 2, October 2003, Pages: 263–270, Yukihiko, Toru Saeki Mima, Taeko Ishii, Atsushi Ogata, Hideyuki Kobayashi, Shiro Ohshima, Tetsushi Ishida, Yuichiro Tabunoki, Hitoshi Kitayama, Masao Mizuki, Yoshinori Katada, Hideki Asaoku, Masayasu Kitano, Norihiro Nishimoto, Kazuyuki Yoshizaki, Masahiro Maeda, Shigeyuki Kon, Naokazu Kinoshita, Toshimitsu Uede and Ichiro Kawase

    Article first published online : 6 NOV 2003, DOI: 10.1046/j.1365-2141.2003.04589.x

  17. Osteocalcin is not a marker of progress in multiple myeloma

    European Journal of Haematology

    Volume 56, Issue 1-2, January-February 1996, Pages: 30–34, Dr. O. Mejjad, X. Le Loët, J. P. Basuyau, J. F. Ménard, P. Jego, Ch. Grisot, A. Daragon, B. Grosbois, L. Euller-Ziegler, M. Monconduit and le Groupe d'Etude et de Recherche sur le Myélome (GERM)

    Article first published online : 24 APR 2009, DOI: 10.1111/j.1600-0609.1996.tb00289.x

  18. You have free access to this content
    A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

    Cancer

    Volume 36, Issue 3, September 1975, Pages: 842–854, Dr. Brian G. M. Durie and Sydney E. Salmon

    Article first published online : 27 JUN 2006, DOI: 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

  19. Advanced lytic lesion is a poor mobilization factor in peripheral blood stem cell collection in patients with multiple myeloma

    Journal of Clinical Apheresis

    Volume 29, Issue 6, December 2014, Pages: 305–310, Sung-Hoon Jung, Deok-Hwan Yang, Jae-Sook Ahn, Yeo-Kyeoung Kim, Hyeoung-Joon Kim and Je-Jung Lee

    Article first published online : 25 APR 2014, DOI: 10.1002/jca.21326

  20. Abstracts of papers presented at the Second Meeting of the European Haematology Association, Paris, France, 29 May-1 June 1996

    British Journal of Haematology

    Volume 93, Issue S2, December 1996, Pages: 1–372,

    Article first published online : 23 MAR 2012, DOI: 10.1111/j.1365-2141.1996.tb08988.x